Advertisement
Research Article

Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes

  • Irene Lurkin,

    Affiliation: Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands

    X
  • Robert Stoehr,

    Affiliation: Institute of Pathology, University of Erlangen, Erlangen, Germany

    X
  • Carolyn D. Hurst,

    Affiliation: Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St. James's University Hospital, Leeds, United Kingdom

    X
  • Angela A. G. van Tilborg,

    Affiliation: Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands

    X
  • Margaret A. Knowles,

    Affiliation: Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St. James's University Hospital, Leeds, United Kingdom

    X
  • Arndt Hartmann,

    Affiliation: Institute of Pathology, University of Erlangen, Erlangen, Germany

    X
  • Ellen C. Zwarthoff mail

    e.zwarthoff@erasmusmc.nl

    Affiliation: Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands

    X
  • Published: January 21, 2010
  • DOI: 10.1371/journal.pone.0008802

Reader Comments (1)

Post a new comment on this article

Publisher's Note: Error in Figure 2

Posted by PLoS_ONE_Group on 31 Jan 2012 at 23:47 GMT

Assay for PIK3CA and NRAS mutations.
http://plosone.org/article/info:doi/10.1371/journal.pone.0008802#pone-0008802-g002

There was an error in Figure 2. The correct Figure 2 can be viewed here: http://www.plosone.org/corrections/pone.0008802.g002.cn.pdf

No competing interests declared.